Q-Linea
1.192
SEK
-1 %
QLINEA
NASDAQ Stockholm
Medical Equipment & Services
Health Care
1 following
-1%
-51.74%
-64.68%
-53.16%
-67.78%
-57.43%
-98.89%
-97.87%
-98.23%
www.qlinea.com/sv
Q-Linea is active in medical technology. The company specializes in the research and development of instruments and consumables. The products are mainly used in the treatment of infectious diseases and blood poisoning and include diagnostic and analysis tools, as well as other related basic sample handlings. The technology is based on the so-called ID and AST technology. The company was founded in 2008 and is headquartered in Uppsala.
Revenue
4.44M
EBIT %
-5,193.47 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
QLINEA
Daily low / high price
1.15 / 1.244
SEK
Market cap
139.66M SEK
Turnover
197.24K SEK
Volume
165K
Latest videos
Financial calendar
Extraordinary general meeting
06.12.2024
Annual report
13.02.2025
Interim report
03.05.2025
General meeting
22.05.2025
Interim report
10.07.2025
Major OwnersSource: Millistream Market Data AB
| Owner | Capital | Votes |
|---|---|---|
| Nexttobe AB | 53.5 % | 53.5 % |
| Fjärde AP-fonden | 7.4 % | 7.4 % |
| Investment AB Öresund | 6.8 % | 6.8 % |
| Nordnet Pensionsförsäkring | 4.7 % | 4.7 % |
| Avanza Pension | 1.6 % | 1.6 % |
| Ulf Landegren | 1.5 % | 1.5 % |
| Cancerfonden - Riksföreningen Mot Cancer | 1.1 % | 1.1 % |
| Aktie-Ansvar Fonder | 1.0 % | 1.0 % |
| Mats Nilsson | 0.9 % | 0.9 % |
| SEB-Stiftelsen | 0.6 % | 0.6 % |
ShowingAll content types
Q-Linea, Audiocast with teleconference, Q3'24
Interim report 1 January - 30 September 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools